Synaptogenix Stock Based Compensation from 2010 to 2024

SNPX Stock  USD 3.13  0.25  8.68%   
Synaptogenix Stock Based Compensation yearly trend continues to be fairly stable with very little volatility. Stock Based Compensation will likely drop to about 958.9 K in 2024. Stock Based Compensation is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. View All Fundamentals
 
Stock Based Compensation  
First Reported
2019-12-31
Previous Quarter
3.4 K
Current Value
3.8 K
Quarterly Volatility
466.3 K
 
Covid
Check Synaptogenix financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Synaptogenix's main balance sheet or income statement drivers, such as Tax Provision of 0.0, Net Interest Income of 1.6 M or Interest Income of 1.6 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.21 or PTB Ratio of 0.12. Synaptogenix financial statements analysis is a perfect complement when working with Synaptogenix Valuation or Volatility modules.
  
Check out the analysis of Synaptogenix Correlation against competitors.
For more information on how to buy Synaptogenix Stock please use our How to Invest in Synaptogenix guide.

Latest Synaptogenix's Stock Based Compensation Growth Pattern

Below is the plot of the Stock Based Compensation of Synaptogenix over the last few years. It is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. Synaptogenix's Stock Based Compensation historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Synaptogenix's overall financial position and show how it may be relating to other accounts over time.
Stock Based Compensation10 Years Trend
Slightly volatile
   Stock Based Compensation   
       Timeline  

Synaptogenix Stock Based Compensation Regression Statistics

Arithmetic Mean3,501,060
Geometric Mean3,171,975
Coefficient Of Variation34.69
Mean Deviation940,306
Median4,182,000
Standard Deviation1,214,614
Sample Variance1.5T
Range3.2M
R-Value(0.72)
Mean Square Error762.9B
R-Squared0.52
Significance0
Slope(195,816)
Total Sum of Squares20.7T

Synaptogenix Stock Based Compensation History

2024958.9 K
2023M
20223.7 M
20213.3 M
20201.7 M

Other Fundumenentals of Synaptogenix

Synaptogenix Stock Based Compensation component correlations

About Synaptogenix Financial Statements

Synaptogenix investors use historical fundamental indicators, such as Synaptogenix's Stock Based Compensation, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Synaptogenix. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Stock Based CompensationM958.9 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Synaptogenix Stock Analysis

When running Synaptogenix's price analysis, check to measure Synaptogenix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Synaptogenix is operating at the current time. Most of Synaptogenix's value examination focuses on studying past and present price action to predict the probability of Synaptogenix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Synaptogenix's price. Additionally, you may evaluate how the addition of Synaptogenix to your portfolios can decrease your overall portfolio volatility.